|
Volumn 9, Issue 5, 2010, Pages
|
Drug screening: Shedding light on tumour-stroma interactions
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORTEZOMIB;
DEXAMETHASONE;
DOXORUBICIN;
IMATINIB;
INTERLEUKIN 6 ANTIBODY;
LUCIFERASE;
REVERSINE;
UNCLASSIFIED DRUG;
ACCESSORY CELL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CELL ACTIVITY;
CELL ASSAY;
CELL INTERACTION;
CELL PROLIFERATION;
CELL SPECIFIC IN VITRO BIOLUMINESCENCE IMAGING ASSAY;
CELL SURVIVAL;
CELL VIABILITY;
COCULTURE;
CYTOKINE RELEASE;
DRUG INHIBITION;
DRUG SCREENING;
DRUG SENSITIVITY;
GENETIC CORRELATION;
HIGH THROUGHPUT SCREENING;
HUMAN;
IN VITRO STUDY;
INTRACELLULAR SIGNALING;
LEUKEMIA;
MOLECULAR MECHANICS;
MULTIPLE MYELOMA;
MYELOMA CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
QUANTITATIVE ANALYSIS;
STROMA CELL;
TREATMENT OUTCOME;
TUMOR CELL;
TUMOR GROWTH;
TUMOR MICROENVIRONMENT;
TUMOR VOLUME;
UPREGULATION;
VALIDATION PROCESS;
|
EID: 77951822985
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3163 Document Type: Article |
Times cited : (2)
|
References (1)
|